首页> 美国卫生研究院文献>Biochemical Journal >Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges.
【2h】

Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges.

机译:载脂蛋白E的结构要求以形成与β-淀粉样蛋白-(1-40)形成SDS稳定的复合物:盐桥的作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Of the three major isoforms of human apolipoprotein E (apoE), apoE4 is a risk factor for the development of Alzheimer's disease. Among possible neurologically relevant differences in the properties of apoE3 and apoE4 is the fact that apoE3 forms an SDS-stable complex with beta-amyloid-(1-40) (Abeta40) with greater avidity than does apoE4. This interaction may sequester potentially toxic species of Abeta or facilitate clearance. To understand more about this difference, we examined whether differences in salt bridges between apoE domains influence the capacity of apoE isoforms to form complexes with Abeta. In apoE3 there is a salt bridge between Arg-61 and Asp-65, while in apoE4 there are salt bridges between Arg-61 and Glu-255, and Arg-112 and Glu-109. Mutation of position 112, which is Cys in apoE3 and Arg in apoE4, to Ala or Lys abolished complex formation, while mutant apoE with Ser at this position retained the capacity to form complex. Substituting Ala for Glu-109 had no effect on the ability of either apoE4 or apoE3 to form complexes. On the other hand, substitution of Thr for Arg-61 in apoE3 abolished, and truncation of apoE3 at position 201 substantially lowered, but did not abolish, complex formation. Neither of these mutations within apoE4 had any affect on its complex formation with Abeta. These results suggest that the nature of the cysteine residue in apoE3 and interactions between the N-terminal and C-terminal domains of human apoE are important for the ability of apoE3 to form an SDS-stable complex with Abeta40.
机译:在人类载脂蛋白E(apoE)的三种主要同工型中,apoE4是阿尔茨海默氏病发展的危险因素。 apoE3和apoE4的性质在神经学上可能存在的相关差异是,与apoE4相比,apoE3与β-淀粉样蛋白-(1-40)(Abeta40)形成SDS稳定的复合物。这种相互作用可能会隔离潜在的Abeta毒性物种或促进清除。为了更多地了解这种差异,我们检查了apoE域之间盐桥的差异是否会影响apoE亚型与Abeta形成复合物的能力。在apoE3中,Arg-61和Asp-65之间存在一个盐桥,而在apoE4中,Arg-61和Glu-255之间以及Arg-112和Glu-109之间存在盐桥。 112位突变,即apoE3中的Cys和apoE4中的Arg,突变为Ala或Lys消除了复合物的形成,而在此位置具有Ser的突变apoE保留了形成复合物的能力。用Ala代替Glu-109对apoE4或apoE3形成复合物的能力没有影响。另一方面,取消了apoE3中Thr取代Arg-61的作用,并且在201位的apoE3的截短显着降低了,但没有消除复合物的形成。 apoE4内的这些突变均不影响其与Abeta的复合物形成。这些结果表明,apoE3中半胱氨酸残基的性质以及人apoE的N端和C端结构域之间的相互作用对于apoE3与Abeta40形成SDS稳定复合物的能力很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号